Philosophiae Doctor - PhD / Tsetse flies (Glossina spp) are the biological vectors for Trypanosomes, the causative magents of Human African Trypanosomiasis (HAT). HAT is a debilitating disease that continues to present a major public health problem and a key factor limiting rural development in vast regions of tropical Africa. To augment vector control efforts, the International Glossina Genome Initiative (IGGI) was established in 2004 with the ultimate goal of generating a fully annotated whole genome sequence for Glossina morsitans. A working draft genome of Glossina morsitans was availed in 2011. In this thesis, transcriptional regulatory features in Glossina morsitans were analysed using the draft genome. A method for TSS identification in the newly sequenced Glossina morsitans genome was developed using TSS-seq tags sampled from two developmental stages of Glossina morsitans. High throughput next generation sequencing reads obtained from Glossina morsitans larvae and pupae were used to locate transcription start sites (TSS) in the Glossina morsitans genome. TSS-seq tag clusters, defined as a minimum number of reads at the 5’ predicted UTR or first coding exon, were used to define transcription start sites. A total of 3134 tag clusters were identified on the Glossina genome. Approximately 45.4% (1424) of the tag clusters mapped to the first coding exons or their proximal predicted 5’UTR regions and include 31 tag clusters that mapped to transposons. A total of 1101 (35.1%) tag clusters mapped outside the genic region and/or scaffolds without gene predictions and may correspond to previously un-annotated transcripts or noncoding RNA TSS. The core promoter regions were classified as narrow or broad based on the number of TSS positions within a TSS-seq cluster. Majority (95%) of the core promoters analysed in this study were of the broad type while only 5% were of the narrow type. Comparison of canonical core promoter motif occurences between random and bona fide core promoters showed that, generally, the number of motifs in biologically functional genomic windows in the true dataset exceeded those in the random dataset (p <= 0.00164, 0.00135, 0.00185 for the narrow, broad with peak and broad without peak categories respectively). Frequency of motif co-occurrence in core promoter was found to be fundamentally different across various initiation patterns. Narrow core promoters recorded higher frequency of the TATA-box and INR motifs and two-way motif co-occurrence showed that the TATA-box-INR pair is over-represented in the narrow category. Broad core promoters showed higher frequency of the BREd and MTE motifs and two-way motif co-occurrence showed that the MTE-DPE pair is over-represented in broad core promoters. TATA-less promoters account for 77% of the core promoters in this analysis. TATA-less core promoters showed a higher frequency of the MTE and INR motifs in contrast to observations in Drosophila where the DPE motif has been reported to occur frequently in TATA-less promoters. These motif combinations suggest their equal importance to transcription in their corresponding promoter classes in Glossina morsitans.

The two human pathogenic sub-species T.b.gambiense and T.b.rhodesiense can be distinguished from the morphologically identical T.b.brucei by their ability to infect humans, enabling them to cause sleeping sickness. This is because they are resistant to lysis by the lytic factor (APOL-I) present in normal human serum (NHS). In T.b.rhodesiense resistance to this lytic factor is due to a truncated VSG gene termed SRA which blocks lysis by interacting with APOL-I in the lysosome. SRA does not exist in T.b.gambiense. The search for a similar truncated VSG gene lead to the identification of a T.b.gambiense specific glycoprotein termed TGSGP. TGSGP transfected alone into the sensitive T.b.brucei is unable to confer resistance to this sub-species. This is either due to incorrect processing of this gene is this sub-species or because TGSGP requires a partner to confer resistance.<p><p>In the search for a partner, the genomic locus of TGSGP was cloned and sequenced. We found that TGSGP is linked to a truncated gene homologous to the S.cerevisiae AUT1 gene, a gene implicated in autophagy and more specifically in membrane expansion. Southern blot hybridization and PCR analysis on genomic DNA from several isolates demonstrated that this feature was a specific to T.b.gambiense. In addition, we observed a correlation between the aut1 allele size and the geographical origin of the isolate.<p><p>Since in trypanosomes lysis by NHS is due to an uncontrolled expansion of the lysosome, we speculated that the truncation of the aut1 allele could be implication in the resistance to human serum. We characterized the genomic organisation of the AUT1 locus. T.b.brucei possesses two native AUT1 alleles whilst T.b.gambiense possesses a truncated aut1 allele, as well as a native AUT1 allele. We showed that in the T.b.gambiense LiTAR isolate (aut1/AUT1), despite the presence of a wild-type allele this gene is no longer expressed at the mRNA and protein level. Our complimentary results by run-on transcription assay showed that the AUT1 region is transcribed but that the messenger is unstable. LiTAR is a functional knock-out for AUT1, but Northern blot analysis on several T.b.gambiense isolates showed that this is not a generalised T.b.gambiense characteristic. <p><p>We explored the role of AUT1 in trypanosomes by invalidation of the AUT1 gene in T.b.brucei and by the over-expression of the AUT1 and aut1 alleles in T.b.brucei. By functional analysis of AUT1 knocked-down cells we showed that AUT1 is not essential in trypanosomes. By recreating in T.b.brucei the T.b.gambiense AUT1/aut1 genotype we were able to show that the expression of the aut1 UTR down-regulated the expression of the wild-type AUT1 allele. We speculated that this may be due to a natural RNAi mechanism. Par northern blot, using probes covering the potential target region of AUT1, we detected a 50nt small RNA specific to T.b.gambiense. In addition, we showed that in a LiTAR strain in which the RNAi pathway was abolished AUT1 expression is restored. <p><p>We continued to investigate TGSGP’s role in the resistance to human serum by invalidation of TGSGP in T.b.gambiense and by expressing TGSGP in the NHS-sensitive T.b.brucei. Because T.b.gambiense cannot be cultured in vitro we established a new in vivo transfection technique and as the knock-out of TGSGP is most probably lethal, we created an inducible RNAi T.b.gambiense cell strain. These indispensable tools will be used to test whether invalidation TGSGP is sufficient to confer resistance to NHS. Many strategies were tested in order to correctly expressing TGSGP in T.b.brucei; in none of these transfectants was TGSGP correctly located in the flagellar pocket as is the case in T.b.gambiense and only partial resistance was ever obtained. In order to identify the factors in human serum that could interacts with TGSGP, we subjected NHS to affinity chromatography using TGSGP as bait. We showed that TGSGP interacts with APOA-I, a major component of HDLs.<p> / Doctorat en sciences, Spécialisation biologie moléculaire / info:eu-repo/semantics/nonPublished

Sleeping sickness, caused by Trypanosoma brucei, is a deadly disease that affects some of the poorest countries in sub-Saharan Africa. Although the disease prevalence is declining, strengthening of the current control efforts, including introduction of more adequate chemotherapeutic options, is needed to prevent the re-emergence of yet another epidemic. Nitroaromatic compounds, such as nifurtimox (in combination with eflornithine) and fexinidazole (in clinical trials), have been recently introduced for the treatment of the second stage of sleeping sickness. These compounds are believed to act as pro-drugs that require intracellular enzymatic activation for antimicrobial activity. Here, the role of the bacterial-like nitroreductase TbNTR as a nitrodrug activating enzyme is examined through overexpression and knock-out studies in T. brucei. Multiple attempts to purify soluble recombinant TbNTR from E. coli were unsuccessful, because the recombinant protein was found to be membrane associated. In keeping with the role of TbNTR in nitrodrug activation, loss of an NTR gene copy in T. brucei was found to be one, but not the only, mechanism that may lead to nitrodrug resistance. Furthermore, in the bloodstream form of T. brucei, resistance was relatively easy to select for nifurtimox, with no concurrent loss of virulence and at clinically relevant levels. More worryingly, nifurtimox resistance led to a decreased sensitivity of these parasites to other nitroaromatic compounds, including a high level of cross-resistance to fexinidazole. Conversely, generation of fexinidazole resistance resulted in cross-resistance to nifurtimox. Should these findings translate to the field, emerging nitrodrug resistance could reverse all recent advances in the treatment of sleeping sickness, made since the introduction of eflornithine 20 years ago. Therefore, all efforts should be made to ensure nitroaromatic drugs are used only in drug combination therapies against sleeping sickness, in order to protect them from emerging resistance.

SUMMARY BACKGROUND Human African trypanosomiasis (HAT), commonly named sleeping sickness, was under control to a certain extent at the beginning of the sixties. In fact, the prevalence rate had then decreased drastically (one case per 10.000 examined inhabitants) for four major reasons: 1. active and exhaustive classical medical prospecting 2. correct treatment administered to patients suffering from trypanosomiasis 3. post-therapeutic follow-up of treated patients 4. vector control involving the community at risk In the Democratic Republic of Congo (DRC), HAT left rural areas to extend to large cities, like Kinshasa. The incidence of HAT in Kinshasa has been increasing since 1996. Until now, there is no indication on knowledge, attitudes and conceptions of HAT in Kinshasa. The major objectives of this study are: to analyse the epidemiological, clinical, sanitary, demographic, socio-economic and socio-cultural characteristics of HAT in Kinshasa to assess the level of knowledge, the attitudes, practices, perceptions, behaviours and local beliefs related to HAT among people residing in Kinshasa endemic area to identify the sanitary, socio-economic, environmental or ecological, socio-demographic and socio-cultural variables forming HAT risk factors in Kinshasa to identify the main predictive factors independent of HAT in Kinshasa. METHODS Population of study and data collection Two methodologies were carried out: a quantitative method based on a structured and pre-tested questionnaire as well as a qualitative approach relying on focus groups discussions. The inquiry took place at two different periods: first, between February 9 and June 3, 2006, then between July 7 and 17, 2007. It is a descriptive and analytic case-control study. Cases were patients suffering from trypanosomiasis notified between January 1st, 2004, and December 31st, 2005, thanks to HAT declaration cards registered to the National Human African Trypanosomiasis Program (PNLTHA). Based on age, sex and living place, each case was paired with two controls declared as HAT-free after clinical examination and a negative Card Agglutination Test for Trypanosomiasis (CATT-Test) performed on total blood. Controls were sampled thanks to a stratified approach during campaigns carried out between February and June 2006. A total of 1,311 individuals, 437 cases and 874 controls, were included in the study. Statistical analysis of data The inquiry data were analysed with EPIINFO, version 3.3.2 (CDC, United States), STATISTICA and SPSS, version 13.0, softwares. A Chi-squared or Fishers exact test was used to compare proportions and a Student t-test allowed the comparison of means. The association between the different factors and HAT was determined by estimating the Odds Ratio (OR) with a 95%-confidence interval and a P value under 0.05. This was performed thanks to a uni- and multivariate logistic regression. RESULTS A great proportion of patients suffering from HAT (79.4%, n = 347) had reached a very advanced stage of the disease, the neurological stage. Among the 1,311 persons included in the study, 52.2% were men and 47.8% were women (not significant difference). They were aged between 10 and 74 years, with a mean of 34.2 ± 14.2 years. Professionally active persons, aged between 20 and 49 years (70.3%), and providing resources essential for the economic development were more frequently affected. The majority of HAT cases (53%; n=230) had recently migrated (migration of people province-born who later settled down in Kinshasa); they were residing in Kinshasa for 5 years. People suffering from trypanosomiasis presented the following clinical characteristics: sleep disorders, characterized by hypersomnia (89% of cases) cervical adenopathy was frequently observed (63% of cases) Fever (72% of cases) Only 37.5% of cases scrupulously respected the recommended post-therapeutic follow-up. Numerous case-patients and controls were illiterates: the optimal level of knowledge was of 44% among case-patients and 37% among controls, with a highly significant difference (P<0.0001). Case-patients and controls believe in the supernatural origin of HAT. They believe HAT might have a divine origin, come from sorcery, from a malediction, or from the transgression of forbidden practices (incest). The study shows 87% of cases vs. 86.3% of controls were in favour of passive screening, with a non significant difference (P>0.05). The multivariate statistical analysis (logistic regression) showed the following variables were associated with HAT acquisition/infection in Kinshasa: residency in peripheral areas: rural areas (adjusted OR: 12.1, 95%IC: 5.7-21.7); eccentric areas (adjusted OR: 8.9, 95%IC: 2.1-38.8), family history of HAT (adjusted OR: 12.9, 95%IC: 7.9-20.8), ignorance regarding the mode of transmission (adjusted OR: 11.2, 95%IC: 5.8-21.7), and household water provision at natural/collective water points (adjusted OR: 6.9, 95%IC: 2.8-17.2) were also risk factors. CONCLUSION The surveillance and control of HAT pass obligatorily through the identification and knowledge of the main determinants of this recrudescent endemic-epidemic if one aims to establish an efficient fighting programme. Among these determinants, it is primordial to highlight: the unintentional ignorance of populations exposed to the HAT risk (obscurantist beliefs) the absence of participative education campaigns for populations residing in risk areas (rural and urban) the deficiency of management by sanitary authorities characterized by the lack of attention paid to the HAT endemic in political circles of decision. the drastic decrease in the budget assigned to health (less than 10 USD per inhabitant per year for healthcare). Once these determinants are known and suppressed, the fight against this plague should consist in: maintaining and reinforcing the surveillance of the endemic area, even in situations of low endemicity, by integrating the mass screening in fixed sanitary structures. This integration should go with the formation of healthcare staff not hardened to the screening and the fight against HAT. improving living conditions and population welfare in general, especially in rural areas. These results bring up different avoidable/modifiable determinants, on which one can act to reduce the morbidity and mortality charges caused by HAT, and involve Kinshasas residents in the fight against the disease./RESUME INTRODUCTION La Trypanosomiase Humaine Africaine (THA), communément appelée Maladie du Sommeil, avait été dans une certaine mesure, maîtrisée au début des années 1960. En fait, le taux de prévalence était alors tombé de façon spectaculaire à des niveaux très bas (un cas pour 10.000 habitants examinés) pour quatre raisons majeures : 1. les prospections médicales classiques actives et exhaustives, 2. le traitement correct administré aux patients trypanosomés, 3. le suivi post-thérapeutique strict des malades traités, 4. la lutte antivectorielle impliquant la communauté à risque. En République démocratique du Congo (RDC), la THA est sortie des milieux ruraux pour sétendre aux grandes villes, comme Kinshasa. Lincidence de la THA est croissante à Kinshasa depuis 1996. Jusquà présent, à notre connaissance, il nexiste pas dindication sur les connaissances, les attitudes et les conceptions de la THA à Kinshasa. Les objectifs majeurs de cette étude sont : analyser les caractéristiques épidémiologiques, cliniques, sanitaires, démographiques, socioéconomiques et socioculturelles de la THA à Kinshasa, évaluer le niveau de connaissances, les attitudes, les pratiques, les perceptions, les comportements et les croyances locales relatives à la THA chez les résidents de la zone endémique de Kinshasa, identifier les variables sanitaires, socioéconomiques, environnementales ou écologiques, sociodémographiques et socioculturelles constituant les facteurs de risque de la THA à Kinshasa, identifier les principaux facteurs prédictifs indépendants de la THA à Kinshasa. METHODES Population détude et collecte des données Deux focalisations méthodologiques ont été utilisées: la méthode quantitative basée sur un questionnaire structuré, prétesté et la méthode qualitative basée sur les focus groups discussions. Lenquête sest déroulée en deux périodes. Dabord du 9 février au 3 juin 2006. Ensuite, du 7 au 17 Juillet 2007. Il sagit dune étude cas-témoins descriptivo-analytique. Les cas étaient des patients trypanosomés identifiés entre le 1 janvier 2004 et le 31 décembre 2005 avec fiches de déclaration de THA au Programme National de Lutte contre la Trypanosomiase Humaine Africaine (PNLTHA). Chaque cas était apparié sur lâge, le sexe et le lieu dhabitation à deux témoins déclarés indemnes de THA après examen clinique et présentant une sérologie négative au Card Agglutination Test for Tryapnosomiasis (CATT-Test) sur sang total, tirés au sort par sondage stratifié au cours des campagnes actives de février à juin 2006. Au total, létude a touché 1311 individus dont 437 cas et 874 témoins. Analyse statistique des données Les données ont été encodées et analysées avec les logiciels EPIINFO version 3.3.2 (CDC, Etats-Unis), STATISTICA version 7.1 et SPSS version 13.0. Le test de Chi-carré et le Fisher exact ont été utilisés pour comparer les proportions et le t de student pour la comparaison des moyennes. Lassociation entre les différents facteurs étudiés et la THA a été déterminée en estimant lOdds Ratio (OR) avec un intervalle de confiance (IC) de 95% et un p inférieur à 0,05. Ceci a été réalisé en utilisant la méthode de régression logistique univariée et multivariée. RESULTATS Une grande proportion des patients trypanosomés (79,4%, n=347) était en phase très avancée de leur infection, au stade neurologique. Parmi les 1311 sujets retenus dans létude, il y avait 52,2% dhommes et 47,8% de femmes, différence non significative (p>0,05). Leur âge variait entre 10 et 74 ans avec une moyenne de 34,2±14,2 ans. Les personnes professionnellement actives âgées de 20-49 ans (70,3%) et pourvoyeuses de ressources nécessaires au développement économique étaient les plus atteintes. La majorité des patients trypanosomés (53% ; n=230) étaient des migrants (migration interne des personnes nées en province et venues sinstaller à Kinshasa) récents dont la durée de séjour à Kinshasa ne dépassait pas 5 ans. Les patients trypanosomés présentaient les caractéristiques cliniques suivantes : les troubles du sommeil caractérisés par lhypersomnie diurne dans 89% des cas, les adénopathies cervicales sont fréquentes, soit 63% des cas observés, la fièvre se retrouve dans 72% des cas. Seuls 37,5% des cas avaient scrupuleusement respecté le suivi post-thérapeutique recommandé. Bon nombre des cas et témoins étaient analphabètes : le niveau optimum de connaissance était de 44% chez les cas et 37% chez les témoins avec une différence hautement significative (p<0,0001). Les cas et les témoins croient à lorigine surnaturelle de la THA. Ils pensent que la THA peut être dorigine divine, provenir de la sorcellerie, dune malédiction, ou encore de la transgression des interdits (inceste). Létude montre que 87% des cas vs 86,3% des témoins étaient favorables au dépistage passif, différence non significative (p>0,05). En analyse statistique par la régression logistique multivariée, les variables suivantes étaient significativement associées à lacquisition/infection de la THA à Kinshasa. la résidence en zones périphériques : zones rurales (OR ajusté 12,1 ; IC à 95% : 5,7-21,7) ; zones excentriques (OR ajusté 8,9 ; IC à 95% : 2,1-38,8), lhistoire familiale de THA (OR ajusté 12,9 ; IC à 95% : 7,9-20,8), lignorance du mode de transmission (OR ajusté 11,2 ; IC à 95% : 5,8-21,7) et lapprovisionnement en eau de ménage dans des points deau naturels/collectifs (OR ajusté 6,9 ; IC à 95% : 2,8-17,2) sont aussi des facteurs de risque. CONCLUSION La surveillance et le contrôle de la THA passent obligatoirement par lidentification, et la connaissance des principaux facteurs déterminants de cette endémo-épidémie en recrudescence si lon veut établir un plan de lutte efficace contre ce fléau. Parmi ces déterminants, il importe de noter notamment : lignorance involontaire (croyances obscurantistes) des populations exposées au risque de THA, labsence des campagnes éducatives participatives des populations résidant dans les zones à risque (rurales et citadines), la mauvaise gestion des autorités sanitaires caractérisée par le peu dattention accordée à lendémie de THA dans les milieux politiques de décision, la diminution drastique du budget alloué à la santé (moins de 10$USA par habitant par an pour les soins de santé). Une fois que ces déterminants sont connus et jugulés, la lutte contre ce fléau devrait consister à : maintenir et renforcer la surveillance de la zone endémique, même en situation de faible endémicité par lintégration du dépistage de masse dans les structures sanitaires fixes. Cette intégration devrait être accompagnée de la formation des personnels soignants non aguerris au dépistage et à la lutte contre la THA, améliorer les conditions de vie et du bien-être de la population en général, et plus particulièrement la population rurale. Ces résultats mettent en évidence divers déterminants contrôlables, sur lesquels on peut agir pour réduire la charge de la morbidité et mortalité attribuée à la THA, et impliquer les habitants de Kinshasa dans la lutte contre cette maladie.

A class of linear diamidines was synthesized for the evaluation as a treatment of Human African Trypanosomiasis. These fused heterocyclic compounds are thiazole[5,4-d]thiazoles and are of interest because the parent compound, 2,5-Bis(4-amidinophenyl)-thiazolo[5,4-d]thiazole HCl salt, which is also called DB 1929, has exhibited a low nanomolar IC50 value against Trypanosoma brucei rhodesiense and has shown selectivity for binding to the human telomere G-quadruplex over that of DNA duplex. A fluoro and a methoxy derivative have been synthesized and are currently undergoing testing for activity and binding affinity. In addition, fluorescence studies of selected diamidines were done to study the effect of structural variation on fluorescence. This data is useful since it can determine what types of moieties are needed to yield a compound that will fluoresce in the higher wavelengths (500 nm and above) of the visible spectrum, which would be advantageous in determining the uptake of the drug in the trypanosome within the endemic areas of Africa with a simple microscope.

This thesis describes bioanalytical methods for measuring melatonin and some anti-infective drugs in biological fluids. Solid-phase extraction (SPE) or protein precipitation was used for enrichment and purification of the analytes and Liquid Chromatography (LC) was used to analyze the samples. Developed methods were validated according to international guidelines. Melatonin is a hormone secreted by the pineal gland with a robust circadian rhythm. Bioanalytical methods for determination of melatonin in plasma and saliva have been developed which were used for monitoring melatonin levels in volunteers and patients suffering from sleep related diseases. Eflornithine (DFMO) is a chiral drug used for the treatment of human African trypanosomiasis. A bioanalytical method for determination of the DFMO enantiomers in plasma, after precolumn derivatization with o-phtalaldehyde and N-acetyl-L-cystein has been developed. The method has been used to study the L- and D-DFMO pharmacokinetics, in order to investigate the possible development of an oral treatment of DFMO. A method for simultaneous determination of three antiretroviral drugs i.e. Lamivudine (3TC), Zidovudine (AZT) and Nevirapine (NVP) in dried blood spots (DBS) was developed. The method was used for drug determination in two subjects after receiving standard antiretroviral treatment. The method seemed well suitable for the determination of 3TC and NVP and in some extent for AZT. Lumefantrine (LF) is one of the active components in a new fixed drug combination recommended by the WHO as a replacement to older drugs that has lost their effect. A method for the determination of LF in DBS was developed. The method is suitable for monitoring of drug treatment in rural settings. Tafenoquine is a new promising antimalarial drug under development. A method for the determination of Tafenoquine in plasma and in DBS is described. The method may be useful in future clinical studies in laboratory environment as well as in rural settings. / Felaktigt tryckt som Digital Comprehensive Summaries of Uppsala Dissertations from the Faculty of Science and Technology 703

The trypanolytic factor of human serum :a trojan horse.<p><p><p>African trypanosomes, the prototype of which is Trypanosoma brucei, are protozoan parasites of huge clinical, veterinary and economical importance. They develop in the body fluids of various mammals (including humans) where they face and manipulate many different aspects of the immune system. The extent of this interplay is pivotal to both host and parasite survival, and depending on parasite virulence and host susceptibility, infection duration ranges from some months to several years. At the end, host survival is invariably compromised.<p><p>Humans and few other primates provide however a striking exception to this fatal outcome. They are indeed fully protected against most trypanosome infections through the presence in their blood of a so-called trypanosome lytic factor (TLF). The TLF is known to circulate mainly in the form of a high density lipoprotein particle characterized by the simultaneous presence of two primate-specific proteins: haptoglobin-related protein (Hpr) and apolipoprotein L-I (apoL-I).<p><p>We have contributed to delineate the respective roles played by Hpr and apoL-I in the lysis process.<p><p>ApoL-I was shown to be the exclusive toxin of the TLF. In its absence humans get fully susceptible to any trypanosome infection. The toxin was shown to kill the parasite after endocytosis through the generation of ionic pores in the lysosomal membrane. Those pores dissipate membrane potential and trigger the influx of chloride ions from the cytoplasm into the lysosomal compartment, leading to an eventually fatal uncontrolled osmotic phenomenon. <p><p>ApoL-I efficient delivery to the parasite relies on Hpr. African trypanosomes indeed fulfil their heme nutritional requirements by receptor-mediated internalization of the complex formed by haptoglobin, an evolutionary conserved acute-phase protein, and hemoglobin, resulting from physiological intravascular hemolysis. This heme uptake by the auxotrophic parasites contributes to both growth rate and resistance against host oxidative burst. In human serum, the trypanosome receptor is unable to discriminate between Hp and the closely related TLF-bound Hpr, explaining TLF efficient endocytosis.<p><p>As such, the TLF acts as a Trojan horse, killing the parasite from inside the cell after having deceived its vigilance through the high similarity between heme-delivering haptoglobin and toxin-associated Hpr. <p> / Doctorat en Sciences / info:eu-repo/semantics/nonPublished

One of Africa’s neglected tropical diseases, African Trypanosomiasis, is not only fatal but also has a crippling impact on economic development. Heat shock proteins play a wide range of roles in the cell and they are required to assist the parasite as it moves from a cold blooded insect vector to a warm blooded mammalian host. The expression of heat shock proteins increases during these heat shock conditions, and this is considered to play a role in differentiation of these vector-borne parasites. Heat shock protein 70 (Hsp70) is an important molecular chaperone that is involved in protein homeostasis, Hsp40 acts as a co-chaperone and stimulates its intrinsically weak ATPase activity. In silico analysis of the T. brucei genome has revealed the existence of 12 Hsp70 proteins and 65 Hsp40 proteins to date. A novel Hsp70, TbHsp70.c, was recently identified in T. brucei. Different from the prototypical Hsp70, TbHsp70.c contains an acidic substrate binding domain and lacks the C-terminal EEVD motif. By implication the substrate range and mechanism by which the substrates are recognized may be novel. The ability of a Type I Hsp40, Tbj2, to function as a co-chaperone of TbHsp70.c was investigated. The main objective of this study was to biochemically characterize TbHsp70.c and its partnership with Tbj2 to further enhance our knowledge of parasite biology. TbHsp70.c and Tbj2 were heterologously expressed and purified and both proteins displayed chaperone activities in their ability to suppress aggregation of thermolabile MDH. TbHsp70.c also suppressed aggregation of rhodanese. ATPase assays revealed that the ATPase activity of TbHsp70.c was stimulated by Tbj2. The targeted inhibition of the function of heat shock proteins is emerging as a tool to combat disease. The small molecule modulators quercetin and methylene blue are known to inhibit the ATPase activity of Hsp70. However, methylene blue did not significantly inhibit the ATPase activity of TbHsp70.c; while quercetin, did inhibit the ATPase activity. In vivo heat stress experiments indicated an up-regulation of the expression levels of TbHsp70.c. RNA interference studies showed partial knockdown of TbHsp70.c with no detrimental effect on the parasite. Fluorescence microscopy studies of TbHsp70.c showed a probable cytoplasmic subcellular localization. In this study both TbHsp70.c and Tbj2 demonstrated chaperone activity and Tbj2 possibly functions as a co-chaperone of TbHsp70.c.

Background: Human African Trypanosomiasis (HAT) also called sleeping sickness is an infectious disease in humans caused by an extracellular protozoan parasite. The disease, if left untreated, results in 100% mortality. Currently available drugs are full of severe drawbacks and fail to escape the fast development of trypanosoma resistance. Due to similarities in cell metabolism between cancerous tumors and trypanosoma cells, some of the current registered drugs against HAT have also been tested in cancer chemotherapy. Here we demonstrate for the first time that the simple ester, ethyl pyruvate, comprises such properties. Results: The current study covers the efficacy and corresponding target evaluation of ethyl pyruvate on T. brucei cell lines using a combination of biochemical techniques including cell proliferation assays, enzyme kinetics, phasecontrast microscopic video imaging and ex vivo toxicity tests. We have shown that ethyl pyruvate effectively kills trypanosomes most probably by net ATP depletion through inhibition of pyruvate kinase (Ki = 3.0±0.29 mM). The potential of ethyl pyruvate as a trypanocidal compound is also strengthened by its fast acting property, killing cells within three hours post exposure. This has been demonstrated using video imaging of live cells as well as concentration and time dependency experiments. Most importantly, ethyl pyruvate produces minimal side effects in human red cells and is known to easily cross the blood-brain-barrier. This makes it a promising candidate for effective treatment of the two clinical stages of sleeping sickness. Trypanosome drug-resistance tests indicate irreversible cell death and a low incidence of resistance development under experimental conditions. Conclusion: Our results present ethyl pyruvate as a safe and fast acting trypanocidal compound and show that it inhibits the enzyme pyruvate kinase. Competitive inhibition of this enzyme was found to cause ATP depletion and cell death. Due to its ability to easily cross the bloodbrain- barrier, ethyl pyruvate could be considered as new candidate agent to treat the hemolymphatic as well as neurological stages of sleeping sickness.

RESUME<p>La Trypanosomiase Humaine Africaine (THA) appelée également « maladie du sommeil» est une maladie parasitaire provoquée par un protozoaire du genre Trypanosoma dont deux sous-espèces (T. brucei gambiense et T. brucei rhodesiense) sont pathogènes à l’homme. La stratégie de lutte contre cette maladie est essentiellement basée sur le dépistage précoce et le traitement des malades, complété avec le contrôle du vecteur. Cependant, l’utilisation du service de dépistage de la THA par les communautés exposées représente un défi majeur. L’adhésion aux campagnes de dépistage actif avec des équipes mobiles spécialisées était en-dessous de 50% dans certains villages endémiques fin des années nonante. De surcroît, l’utilisation des services de santé fixes en RDC est si faible que ceci compromet le dépistage passif dans les formations sanitaires fixes. Notre hypothèse est que cette faible utilisation des services de santé pourrait elle-même être due à un problème d’acceptabilité du dépistage et traitement de la THA par les communautés vivant dans les zones de transmission de la THA. Tout ceci compromet l’élimination de la THA comme problème de santé publique, un but que s’est fixé la communauté internationale d’ici 2020.<p>Ce travail a comme objectif d’explorer cette dimension socioculturelle de la maladie qui est souvent négligée dans le contrôle de la THA et générer une meilleure connaissance de ces aspects.<p><p>Nous avons réalisé cinq études en total pour adresser la question de la sous-utilisation des services de dépistage et traitement de la THA par les communautés et sa relation avec l’acceptabilité des services. Nous avons d’abord développé une première étude qui évalue les résultats du traitement de la THA en analysant rétrospectivement les données de routine du programme de contrôle de la THA pour l’année 2006 à 2008. Ensuite, nous avons réalisé trois études qualitatives par focus group (groupe focalisé) et entretiens individuels pour documenter la dimension socioculturelle de la lutte contre la THA. D’abord une étude qui a exploré les perceptions sur la THA dans la communauté, suivi par une étude qui explore les perceptions sur le traitement de la THA et une autre qui se concentre sur les pratiques diagnostics des professionnels de santé face à un syndrome neurologique en contexte de ressources limitées. <p><p>Une cinquième étude combine une enquête-ménage avec des focus groups et des entretiens individuels pour explorer les perceptions de la communauté sur la santé en général et les services de santé. <p>Nous avons comparé les obstacles à l’utilisation des services de dépistage et traitement de la THA identifiés dans ce travail avec les messages de sensibilisation sur la THA utilisés au programme de contrôle de la THA en RDC et nous avons développé des recommandations stratégiques.<p><p>L’évaluation des indicateurs de performances sur l’issue de traitement montre que le taux de suivi post-thérapeutique est faible dans son ensemble :25 % pour le premier suivi de six mois et moins d’un pourcent des patients revient pour la dernière visite de contrôle au mois 24. Nous avons aussi observé dans cette étude un taux d’échec au mélarsoprol et à la pentamidine respectivement de 30% et de 22 % au Kasaï Oriental qui sont cependant difficilement interprétables, car le dénominateur est incomplet. Comme très peu de patients reviennent au contrôle post-thérapeutique, cette proportion est probablement biaisée vers ceux qui sont en échec de traitement.<p><p>L’étude de perception de la THA montre que la maladie est bien connue dans les communautés vivant dans les zones à risque. Par contre, plusieurs obstacles au dépistage et traitement de la THA ont été identifiés. Les plus importants sont :la toxicité des médicaments de la THA, les obstacles financiers, l’inadéquation entre le programme de dépistage des équipes mobiles et les occupations des communautés, les interdits qui accompagnent le traitement de la THA, le manque de confidentialité et la peur de la ponction lombaire. <p>L’étude sur la perception du traitement de la THA a montré que le mélarsoprol est perçu comme un médicament toxique et est surnommé « médicament des interdits ». Par contre, le régime NECT est perçu comme un nouveau médicament moins toxique qui a rendu les interdits liés au mélarsoprol obsolètes sauf un seul, celui de ne pas avoir de rapport sexuel pendant la période de traitement et de suivi post thérapeutique qui est de 6 mois. Les interdits ont été instaurés de manière empirique par les professionnels de santé et les communautés pour mitiger les effets indésirables du mélarsoprol. Leur violation pourrait entrainer des conséquences graves et mortelles. Ces interdits sont fortement ancrés dans les croyances de la communauté et constituent aujourd’hui un obstacle au dépistage et traitement. <p><p>L’étude sur les pratiques diagnostiques des professionnels de santé en matière de syndrome neurologique en contexte de ressources limitées a montré qu’en zone rurale le diagnostic est principalement clinique. Les obstacles perçus au diagnostic de confirmation sont essentiellement d’ordre financier puisque le patient doit tout financer de sa poche. Autres obstacles évoqués sont le manque d’outils de diagnostic et la perception de la communauté qui voit le clinicien comme un devin (petit dieu) ou oracle capable de « deviner » directement la maladie sans passer par un processus diagnostique de laboratoire.<p>L’étude sur les perceptions de la santé et des services de santé a montré que les capacités de travailler (82%) et les capacités de se mouvoir (66%) sont les signes de bonne santé les plus perçus. 90% des responsables des ménages perçoivent positivement la santé de leur ménage. Les opinions sur le service de santé sont partagées.<p><p>Les études présentées dans ce travail ont généré des nouvelles connaissances sur la dimension socioculturelle de la THA. L’analyse des messages de sensibilisation sur la THA utilisés par le programme de contrôle de la THA en RDC en termes de comparaison avec les obstacles au dépistage et traitement de la THA identifiés dans ce travail montre que ces aspects socioculturels bien qu’étant des véritables goulots d’étranglements dans la dynamique de la lutte contre la THA ne sont pas bien ciblés par la communication sur la THA. <p>Les perspectives des communautés exposées au risque de la THA doivent être adressées par un dialogue continu entre professionnels de santé et communautés adapté aux réalités locales. Ainsi il sera possible d’améliorer de manière opérationnelle les stratégies d’information, éducation et communication, et de façon plus large, le dépistage et traitement de la THA en intégrant la dimension socioculturelle de la THA dans la politique de lutte contre la THA. <p><p>SUMMARY<p>Human African Trypanosomiasis (HAT), also known as “sleeping sickness” is a parasitic disease caused by protozoa of the species Trypanosoma. There are two types that infect humans, Trypanosoma brucei gambiense and Trypanosoma brucei rhodesiense. The strategy used to control sleeping sickness consists of early case detection and treatment of patients, together with vector control. Meanwhile, utilization/access to HAT screening by the affected communities remains a major challenge. Adherence to active screening programs with mobile units was below 50% in certain endemic villages end of the 90’s. Moreover, utilization of fixed health facilities in DRC is so low that it compromises passive case finding. Our hypothesis is that this low utilization of health services is caused by a problem of acceptance of case detection and treatment of HAT by the communities living in the HAT transmission zones. This compromises the target of the international community to eliminate HAT as a public health problem by 2020. This thesis wants to explore and tries to generate more knowledge on the socio-cultural aspect that is often neglected in the control of HAT. <p><p>We conducted five studies to address the lack of community participation in HAT screening and treatment activities and the relation with acceptance of these services. <p>The first study evaluated the results of HAT treatment by retrospectively analyzing data of the routine HAT control program for the period 2006-2008. <p><p>Afterwards we performed three qualitative studies consisting of focus group discussions and individual interviews to document the socio-cultural dimension of the fight against HAT. The first study explored the community perceptions regarding sleeping sickness. The second study explored the perceptions regarding HAT treatment and a third study focused on diagnostic practices of health professionals in low-resource settings facing a neurological syndrome. <p><p>The fifth study consists of a household survey, focus group discussions and individual interviews to explore community perception regarding health in general and health services. We compared the identified barriers to screening and treatment of HAT with awareness messages on sleeping sickness used by the HAT control program in DRC and we developed strategic recommendations. The evaluation of performance indicators for treatment showed that compliance with post-treatment follow-up is very poor: 25% for the first post-treatment follow-up examination at six months and less than 1% of the patients returns for the final examination at 24 months. In this study we also observed a treatment failure rate of respectively 30% and 22% for melarsoprol and pentamidine in Kasai-Oriental. However, these date are difficult to interpret because of an incomplete denominator. As only few patients return for follow-up visits, this proportion is probably biased towards those in treatment failure.<p> <p>The study on the perception of sleeping sickness shows that the disease is well known amongst the communities living in the endemic areas. However, several screening and treatment barriers were identified. The most important are: drug toxicity, financial barriers, the incompatibility between the itineraries of the mobile screening teams and the local communities’ activities, the prohibitions related to HAT treatment, lack of confidentiality and fear of lumbar punctures. The study on the perceptions regarding HAT treatment show that melarsoprol is perceived as a toxic drug and is nicknamed the ‘taboo drug’. On the other hand the NECT regime is perceived as the new drug that is less toxic and that has abolished all the taboos of melarsoprol with the important exception of sexual intercourse during the treatment period and the post-treatment follow-up period of six months. <p><p>The prohibitions have been established empirically by healthcare providers and communities to mitigate the side effects of the melarsoprol regimen. Violating these restrictions is believed to cause severe and sometimes mortal complications. Communities adhere strictly to these prohibitions and this constitutes a barrier for HAT screening and treatment.<p><p>The study focusing on diagnostic work-up of neurological syndromes in low-resource settings by health care providers has shown that in rural areas diagnosis is usually clinical. Barriers to confirmation of diagnosis are mainly related to the purchasing power of the patient. Other reported barriers are a lack of diagnostic tools and the communities’ perceptions associated with the care provider. Clinicians are perceived as diviners being able to directly identify the cause of the illness without using laboratory tests. The study regarding the perceptions on health and health services has shown that ability to work (82%) and ability to move (66%) are the most perceived signs of good health. 90% of the household responsibles positively perceive the health of their family. The opinions on the health services are divided. <p><p>The studies presented in this thesis have generated new insights on the socio-cultural dimension of HAT. The analysis of the awareness messages on HAT in DRC compared with the reported HAT screening and treatment barriers have shown that <p>although these sociocultural aspects are real bottlenecks in the dynamic of the fight against HAT, they are not targeted by the communication on HAT. <p><p>The prospects for communities at risk of HAT should be addressed through continuous dialogue between health professionals and communities adapted to local realities.<p><p>It will thus be possible to operationally improve the information strategies, education and communication, and more broadly, screening and treatment of HAT by integrating the socio-cultural dimension in the fighting policy against sleeping sickness.<p> / Doctorat en Sciences / info:eu-repo/semantics/nonPublished